Increased rate of venous thrombosis may be associated with inpatient dihydroergotamine treatment

Conclusions:
IV dihydroergotamine treatment may be associated with an increased risk of catheter-associated venous thrombosis. A low threshold for diagnostic ultrasound investigation is appropriate because anticoagulation therapy was frequently required.

Source: Neurology - July 17, 2017 Category: Neurology Authors: Tso, A. R., Patniyot, I. R., Gelfand, A. A., Goadsby, P. J. Tags: Migraine, All Clinical Neurology, Clinical trials Observational study (Cohort, Case control) ARTICLE Source Type: research